ID   CMT64
AC   CVCL_2406
SY   CMT-64; CMT.64; CMT 64; C57 Mouse Tumor 64
DR   ECACC; 10032301
DR   Wikidata; Q54813855
DR   Ximbio; 151447
RX   PubMed=1253168;
RX   PubMed=9347924;
RX   PubMed=19003861;
CC   Omics: Proteome analysis by 2D-DE/MS.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 07-09-18; Version: 9
RX   PubMed=1253168;
RA   Franks L.M., Carbonell A.W., Hemmings V.J., Riddle P.N.;
RT   "Metastasizing tumors from serum-supplemented and serum-free cell
RT   lines from a C57BL mouse lung tumor.";
RL   Cancer Res. 36:1049-1055(1976).
RX   PubMed=9347924; DOI=10.1016/S0300-483X(97)00108-X;
RA   Malkinson A.M., Dwyer-Nield L.D., Rice P.L., Dinsdale D.;
RT   "Mouse lung epithelial cell lines -- tools for the study of
RT   differentiation and the neoplastic phenotype.";
RL   Toxicology 123:53-100(1997).
RX   PubMed=19003861; DOI=10.1002/pmic.200800299;
RA   Zhang K., Wrzesinski K., Stephen J.F., Larsen P.M., Zhang X.,
RA   Roepstorff P.;
RT   "Comparative proteome analysis of three mouse lung adenocarcinoma CMT
RT   cell lines with different metastatic potential by two-dimensional gel
RT   electrophoresis and mass spectrometry.";
RL   Proteomics 8:4932-4945(2008).